Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 1,365

Document Document Title
WO/2020/156360A1
A cholinesterase inhibitor polymorph, wherein specifically disclosed are a succinic octahydroacridine polymorph, a corresponding crystal composition and pharmaceutical composition, and applications thereof. The compound succinic octahydr...  
WO/2020/151799A1
The present invention relates to improved (simplified/easier, more robust and more reproducible) methods for identification of carbohydrates compositions, e.g. out of complex carbohydrate mixtures, as well as the determination of carbohy...  
WO/2020/151804A1
Sulfonated 2(7)-aminoacridone and 1-aminopyrene dyes and their use as fluorescent tags, in particular for carbohydrate analysis The invention relates to fluorescent dyes with multiple negatively charged groups in their ionized form which...  
WO/2020/124771A1
The present invention relates to a thermally activated delayed fluorescent compound, a preparation method therefor and an organic electroluminescent diode device thereof. The thermally activated delayed fluorescent compound has a structu...  
WO/2020/123482A1
Provided herein are small molecule compounds and methods inhibiting human sulfotransferase 1A3 (SULT1A3) using these small molecule compounds. Methods of manufacturing and treatment are also disclosed.  
WO/2020/100013A1
The present invention addresses the problem of providing an organic compound having a small refractive index. The present invention also provides a novel organic compound having a small refractive index and an electron-donating property....  
WO/2020/082601A1
Disclosed are a dark red photothermally activated delayed fluorescence material, a synthesis method therefor and an electroluminescent device. The dark red photothermally activated delayed fluorescence material is a target compound, whic...  
WO/2020/083327A1
Disclosed in the present invention is an organic compound containing a spirobifluorene structure, having a structure as represented by chemical formula (1), wherein Ar1(Ar2)N-(S1)m- and -(S2)n-NAr3(Ar4) are different, and have symmetrica...  
WO/2020/073479A1
The invention relates to the technical field of organic light-emitting materials, in particular to an organic light-emitting compound, a preparation method therefor, and an organic electroluminescent device containing the organic light-e...  
WO/2020/073480A1
The present application relates to the technical field of organic light-emitting materials, and relates in particular to an organic light-emitting compound, a preparation method therefor, and an organic light-emitting device containing t...  
WO/2020/061537A1
Provided are methods for preparing pathogen-inactivated whole blood and other pathogen-inactivated blood product compositions, as well as kits and compositions related thereto.  
WO/2020/056860A1
The invention discloses a 9,10-dihydroacridine derivative represented by formula (I). The compound has an appropriate HOMO energy level that matches an anode and a light-emitting layer when the compound is used as a material of a hole tr...  
WO/2020/048043A1
Disclosed is an aniline compound for preventing or treating a mental disorder. The compound has a structure represented by formula I, and the definition of each substituent is as described in the specification and claims. Also disclosed ...  
WO/2020/050729A1
The invention relates to a radioisotope-labelled compound of quaternary ammonium salt of a polycyclic aromatic amine with formula I, wherein the wavy line indicates a single bond between the non-nodal carbon atom of a polycyclic aromatic...  
WO/2020/020178A1
An organic compound as shown in formula (1). Ar 2 has a structural formula as shown in formula (2), and a plurality of Ar 2 may be the same or different. The compound as shown in formula (1) can be used as a luminescent layer material of...  
WO/2019/207604A1
The present invention underlying this instant application prepares a library based on tacrine, and discloses and claims derivatives of a heterocyclic compound tacrine with the basic molecular formula C13H14NNH2, and the structural formul...  
WO/2019/194136A1
Provided are a photosensitive composition having an excellent sensitivity, a cured film, a method for manufacturing a color filter, a color filter, a solid-state imaging element, and an image display device. The photosensitive compositio...  
WO/2019/176754A1
The present invention provides: a photoelectric conversion element which has a photoelectric conversion film that has a narrow half width of the absorption peak; an imaging element; an optical sensor; and a compound. A photoelectric conv...  
WO/2019/172830A1
The present disclosure concerns use of compounds of formula I, or salts thereof, as reactive matrices for desorption and laser ablation ionization spectrometry. The disclosure further concerns compounds of formula II, or salts thereof, a...  
WO/2019/145375A1
There is provided herein compounds of formula (I) and pharmaceutically-acceptable salts and/or detectably-labelled derivatives thereof, wherein R1 to R3, X, Y, n and m have meanings as provided in the description, together with formulati...  
WO/2019/100061A1
Compounds of Formula I or pharmaceutically acceptable salts or esters thereof capable of binding to and modulating the activity of a stimulator of interferon genes (STING) protein are provided. Methods involving compounds of Formula I as...  
WO/2019/098542A1
The present specification relates to a heterocyclic compound of chemical formula 1 and an organic photoelectric device comprising the same.  
WO/2019/094788A1
The present technology relates to compounds that inhibit human Ly6K and homologs thereof. Also disclosed are methods of using such compounds to: inhibit activity of a Ly6K protein in a cell; decrease migration, colony formation, and/or p...  
WO/2019/085684A1
Disclosed in the present invention are a cyanobenzene-containing or thiocyanobenzene-containing compound and applications thereof in organic electroluminescent devices. The compound is formed by cyanobenzene or thiocyanobenzene groups, h...  
WO/2019/072932A1
The present invention relates to compounds comprising a TAE structure, for use as a layer material for electronic devices, and to an organic electronic device comprising the layer material, and a method of manufacturing the same.  
WO/2019/072928A1
The present invention relates to compounds comprising a TAE structure, for use as a layer material for electronic devices, and to an organic electronic device comprising the layer material, and a method of manufacturing the same.  
WO/2019/046278A1
The present invention relates to payloads containing functionalized platinum-(benz)acridine hybrid agents as cytotoxic warheads and a method of synthesizing the payloads. The payload can be regioselectively conjugated to a biologically a...  
WO/2019/039597A1
Provided is a new donor-acceptor compound that emits light even in a solid state. The present invention provides an organic optical material in which (1) a conjugated molecule that has (a) at least one electron-donating site, (b) at leas...  
WO/2019/036377A1
The present disclosure provides certain tricyclic compounds that are histone methyltransferases G9a and/or GLP inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of G9a and/or GLP such as cancers an...  
WO/2019/020654A1
The present application relates to a spirobifluorene derivative of a specific formula (I) which is suitable for use in electronic devices.  
WO/2019/002190A1
The present application relates to a spirobifluorene derivative of a specific formula (I) which is suitable for use in electronic devices.  
WO/2018/230854A1
The present invention relates to a novel acridine derivative, and an organic electroluminescent device comprising same. The acridine derivative of the present invention has an intramolecular electron donor and electron receptor, and has ...  
WO/2018/217538A1
Disclosed is a method of making substituted acridines. The method includes the step of reacting a bis(halophenyl) amine with an alkyne for a time and at a temperature to yield a substituted acridine.  
WO/2018/198975A1
Provided is a light-emitting element having excellent luminance life. Disclosed is a light-emitting element comprising a positive electrode, a negative electrode, a first organic layer provided between the positive electrode and the nega...  
WO/2018/151678A1
The present invention relates to heterocyclic compounds having the general Formula (I) wherein W1, W2, W3, W4, W7, W8, R1, R2, R3, R4, X2, X3, X4, Z1, Z2, Z3, Q, n and m are as defined herein, or a pharmaceutically acceptable salt thereo...  
WO/2018/137494A1
Provided are an organic emitter molecule and an optoelectronic device comprising the organic emitter molecule. Relaxation of charge transfer triplet (3CT) of roughly equal energy and an intersystem crossing process after excitation of th...  
WO/2018/083635A3
Disclosed are tricyclic heterocyclic compounds having kinase inhibitory activity, pharmaceutical compositions and kits comprising the compounds, and use of the compounds in the treatment of or in medicaments for the treatment of various ...  
WO/2018/078005A1
The present invention relates to amido-substituted cyclohexane compounds of general formula (I) : in which A, R4, R6, R7, R8, R9, R10 and R11 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful...  
WO/2018/077689A1
The present invention relates to a compound of an acridine derivate as well as of an organic semiconductor material an organic semiconductor layer, an electronic device comprising the acridine derivative, a device comprising an organic l...  
WO/2017/031156A8
Method of using ureidomustine (BO-1055), a water-soluble NDA cross-linking agent, in the treatment of a cancer, selected from the group consisting of various types of human leukemia [such as acute myeloid leukemia (ALL) and acute B Lymph...  
WO/2018/032967A1
Disclosed are a 9-phenylacridine macromolecule photosensitizer, and a preparing method and use thereof. The 9-phenylacridine macromolecule photosensitizer comprises at least one of the compounds having a structure as shown in formula (I)...  
WO/2018/033085A1
Disclosed are a compound using anthrone as a core and applications thereof in an organic electroluminescent component. The compound uses anthrone as a parent core, which is connected to an aromatic heterocyclic group, so that the molecul...  
WO/2018/020974A1
Provided are the following: a sulfonium salt which does not contain a toxic metal and which exhibits higher cationic polymerization performance and crosslinking performance than a tetrakis(pentafluorophenyl)borate salt; a heat- or photo-...  
WO/2017/059401A3
Described are compounds that inhibit androgen receptor action, pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating disorders and conditions in a subject.  
WO/2018/006059A1
Alkaline phosphatase chemiluminescent substrate formulations are provided exhibiting rapid incubation periods and improved stability for use in immunoassays.  
WO/2017/216299A1
The object of the present invention are compounds comprising at least one donor group and at least one acceptor group, as described herein, which are characterized by a pronounced CT character. The invention also relates to the use there...  
WO/2017/215549A1
Disclosed are an organic electroluminescent compound and an application thereof. The structural formula of the compound is as shown in general formula (1). The material has good fluorescence quantum efficiency and electroluminescence eff...  
WO/2017/207596A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices, which comprise these compounds.  
WO/2017/205425A1
Described herein are molecules for use in organic light emitting diodes comprising at least one moiety A, at least one moiety D, and at least one moiety B.  
WO/2017/155102A1
Provided is a compound which comprises 2 or more donor groups having different structures and a linking group that links these donor groups, wherein the linking group is an aromatic group constituted from 1 or more benzene rings optional...  

Matches 1 - 50 out of 1,365